Patents by Inventor Andrew William Heath

Andrew William Heath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TB VACCINE
    Publication number: 20110189208
    Abstract: The invention relates to a vaccine useful in therapy and prevention of mycobacterial infections.
    Type: Application
    Filed: September 22, 2009
    Publication date: August 4, 2011
    Inventors: Andrew William Heath, Evy De Leenheer
  • Idiotype Vaccination with Bispecific and Multispecific Immunoglobulin Molecules
    Publication number: 20080317751
    Abstract: The present application relates to immunoglobulin polypeptides comprising at least two immunoglobulin complementarity determining regions, one that binds to an immune receptor and the other which comprises an idiotype to which an immune response is desired.
    Type: Application
    Filed: June 15, 2006
    Publication date: December 25, 2008
    Inventor: Andrew William Heath
  • Vaccination method
    Publication number: 20020136722
    Abstract: The invention relates to adjuvants comprising CD40 ligands crosslinked to antigens, wherein the adjuvants have reduced toxicity and adjuvants comprising CD40 ligands crosslinked to viral antigens.
    Type: Application
    Filed: January 28, 2002
    Publication date: September 26, 2002
    Inventor: Andrew William Heath
  • T-cell dependent vaccine and the cell surface receptor CD28
    Publication number: 20020098184
    Abstract: The invention relates to a novel vaccine suitable for enhancing T-cell dependent immunity comprising a T-cell dependent antigen, such as a soluble protein, and an associated adjuvant, the adjuvant being adapted to stimulate a T-cell lymphocyte via the cell surface receptor CD28.
    Type: Application
    Filed: February 8, 2002
    Publication date: July 25, 2002
    Inventor: Andrew William Heath
  • Novel vaccine development
    Publication number: 20020086026
    Abstract: The invention relates to a novel antigen that is capable of stimulating the T-cell lymphocyte surface receptor CD40. The adjuvant is a ligand adapted for this purpose. The invention also relates to a novel vaccine incorporating the aforementioned adjuvant and also ideally an antigen that is either a T-cell dependent antigen or a T-cell independent antigen.
    Type: Application
    Filed: August 24, 2001
    Publication date: July 4, 2002
    Inventor: Andrew William Heath